FAST International Company


Organization Address
JLABS @ Toronto, Toronto, ON M5S 3E1, Canada


AmacaThera is a Toronto-based biotechnology company focused on developing and commercializing a unique, injectable hydrogel platform technology for a wide range of medical applications.  AmacaThera’s platform technology addresses the critical problem of sustaining therapeutic delivery of pharmacological agents for multiple disease areas.  The platform is patent protected and compatible with a wide range of therapeutics and encapsulation techniques, which enables sustained release products having release profiles from days to months.

A combination of deep experience in formation development and progress with the lead asset leads to the ability to rapidly formulate new products that due to the constituents of the hydrogel can be rapidly advanced through the clinic.

AmacaThera’s first product based on the platform is currently entering the clinic with Phase 1 data expected in Q1 of 2021.  AmacaThera is actively seeking co-development partnerships to develop sustained release formulations of partner APIs